Anuh Pharma (BOM:506260) FFO


BOM:506260 Anuh Pharma Ltd BOM:506260
81 GF Score
Price ₹78.93
GF Value ₹105.51
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Anuh Pharma FFO?

FFO (Funds from operations) only applies to REITs.

BOM:506260
81GF Score
Anuh Pharma Ltd BOM:506260
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Anuh Pharma (BOM:506260) Overvalued in 2026?

Based on GuruFocus' analysis, Anuh Pharma stock appears to be undervalued. The current stock price of ₹78.93 is trading 25.2% below its estimated GF Value™ of ₹105.51. GuruFocus considers Anuh Pharma to be Modestly Undervalued.

Key valuation signals for BOM:506260:

  • FFO:
  • GF Value™: ₹105.51 vs. price of ₹78.93 (25.2% below fair value)
  • GF Score™: 81/100 with 1 warning sign

No single metric tells the full story. See the BOM:506260 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Anuh Pharma Business Description

Other Exchanges ANUHPHR:India
Address Dr. Annie Besant Road, North Wing, 3-A, Shiv Sagar Estate, Worli, Mumbai, MH, IND, 400 018
Anuh Pharma Ltd is engaged in the business of manufacturing and selling of Bulk drugs and chemicals. Geographically, it derives a majority of revenue from India. Its product categories include macrolides, anti-TB, anti-malarial, anti-bacterial, anti-hypertension, expectorant, quinolones, and others. The company generates revenue from the sale of Branded Prescription drugs, Over-the-Counter (OTC) drugs and Generic Prescription drugs.
81GF Score

Get the complete analysis for BOM:506260

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹78.93
Price
₹105.51
GF Value